In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.
The anti-science, anti-medicine mindset of Health and Human Services Secretary Robert F. Kennedy Jr. is killing people by quashing life-saving vaccines.
Billionaire Philippe Laffont Just Dumped CoreWeave and Opened a Position in a Stock That Soared Nearly 50% in January.
Traditionally, vaccines protect against one particular pathogen, but in this study, Stanford Medicine researchers created a vaccine that successfully offered immunity from respiratory viruses, ...
BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...
The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.
COVID-19 vaccination showed effectiveness in reducing hospitalizations and severe disease outcomes associated with the SARS-CoV-2 JN.1 lineage, according to a recent study published in JAMA Network ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
The FDA will review Moderna’s revised application for an mRNA flu vaccine after earlier testing concerns, with approvals being sought for adults 50 and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results